A growing body of evidences have suggested that Cav-1 is overexpressed and associated with metastatic progression of various cancers including prostate cancer[28], lung cancer[29], renal cancer[30] and esophageal cancer[8]. This evidence concerns the gene CAV1 and renal carcinoma.